A Study to Explore the Role of Gut Flora in COVID-19 Infection

Launched by PROGENABIOME · Apr 20, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at the role of gut bacteria, or gut flora, in people who have COVID-19. Researchers want to find out if the virus that causes COVID-19, called SARS-CoV-2, can be found in the stool (poop) of infected patients. This is important because it could help us understand how the virus spreads and how it affects the body.

To join the study, participants need to be at least 18 years old and have a confirmed COVID-19 infection within the last week. They also need to sign a consent form, which shows they understand what the study involves. However, people who have had certain surgeries related to their intestines or those receiving specific types of nutrition may not be eligible. If you decide to participate, you can expect to provide stool samples and answer questions about your health, all while helping researchers learn more about COVID-19 and its effects on the gut.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
• • 2. Male or female of 18 years of age or older
• • 3. Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening
• Exclusion Criteria:
• • 1. Refusal to sign informed consent form
• • 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
• • 3. Postoperative stoma, ostomy, or ileoanal pouch
• • 4. Treatment with total parenteral nutrition